Contract award · 1 Jul 2025

NHS Branded Medicines Tranche B - MAE & NOFE - 1 September 2025

NHS England awarded “NHS Branded Medicines Tranche B - MAE & NOFE - 1 September 2025” to Abbvie Ltd, Accord-UK Ltd, Alexion Pharmaceuticals for £986m.

Medical equipment & pharmaceuticalsNorth West

BuyerNHS England
Value £986m
WinnersAbbvie Ltd, Accord-UK Ltd SME +19 more

Open competition

Open procedure: the contract was advertised and any supplier could submit a bid.

Key facts

Buyer
NHS England · Body governed by public law
Value
£986,282,758
Procedure
Open procedure (above threshold)
Sector
Medical equipment & pharmaceuticals · Pharmaceutical products (CPV 33600000)
Timeline
  1. Contract date1 Jul 2025
  2. Published29 Jul 2025Published 28 days after the contract date

Description

NHS Framework Agreement for Branded Medicines - Tranche B - NOFE & MAE and Eculizumab & Ravulizumab for London & SOFE - 01 September 2025 CM/PHR/24/5680/01 - NHS Framework Agreement for Branded Medicines - Tranche B for North of England and Midlands & East. Period of Framework Agreement: 01 September 2025 to 31 August 2027 with an option or options to extend (at the Authority's discretion) for a period or periods up to a total of 24 months. CM/PHR/24/5680/02 - NHS Framework Agreement for Branded Medicines - Eculizumab and Ravulizumab for London & SOFE. Period of Framework Agreement: 01 September 2025 to 31 August 2026 with an option or options to extend (at the Authority's discretion) for a period or periods up to a total of 12 months.

About the suppliers

More from NHS England

All contracts

More won by Abbvie Ltd

All contracts

Recent medical equipment & pharmaceuticals contracts

Sector overview